Pfizer Loses Trademark Suit Over Envacar In China

Law360, New York (December 21, 2004, 12:00 AM EST) -- U.S. drug maker Pfizer Inc has lost a drug trademark lawsuit it filed with the Beijing No.1 Intermediate People's Court at the end of September against China's State Administration for Industry and Commerce.

Pfizer had accused the administration of unfairly rejecting its application for a trademark registration in China for Envacar a drug used in treating high blood pressure. Starting in September 2001, the drug maker twice submitted an application to SAIC to register Envacar as the trademark for the high blood pressure drug.

However, SAIC...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.